Metastasis suppressor NME1 regulates melanoma cell morphology, self-adhesion and motility via induction of fibronectin expression

被引:13
|
作者
Novak, Marian [1 ]
Leonard, Mary Kathryn [1 ]
Yang, Xiuwei H. [2 ]
Kowluru, Anjan [3 ]
Belkin, Alexey M. [1 ,4 ]
Kaetzel, David M. [1 ]
机构
[1] Univ Maryland, Sch Med, Greenebaum Canc Ctr, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA
[2] Univ Kentucky, Coll Med, Dept Mol & Biomed Pharmacol, Lexington, KY USA
[3] Wayne State Univ, Dept Pharmaceut Sci, John D Dingell VA Med Ctr, Detroit, MI USA
[4] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA
基金
美国国家卫生研究院;
关键词
fibronectin; melanoma; motility; NME1; ACID RECEPTOR EDG2; PROGNOSTIC-SIGNIFICANCE; NM23; EXPRESSION; IN-VITRO; MIGRATION; CANCER; INVASION; RHO; CARCINOMA; PATHWAYS;
D O I
10.1111/exd.12697
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Expression of the metastasis suppressor NME1 in melanoma is associated with reduced cellular motility and invasion in vitro and metastasis in vivo, but the underlying molecular mechanisms are not completely understood. Herein, we report a novel mechanism through which NME1 controls melanoma cell morphology via upregulation of the extracellular matrix (ECM) protein fibronectin. Expression of NME1 strongly suppressed cell motility in melanoma cell lines 1205LU and M14. The resulting sedentary phenotype was associated with a more flattened appearance and marked increases in actin stress fibre and focal adhesion formation. NME1-induced focal adhesions were colocalized with dense deposits of fibronectin, which were absent or minimal in the corresponding NME1-deficient parental lines. NME1 was a strong inducer of fibronectin mRNA and protein expression, shown with reciprocal approaches of forced NME1 expression and shRNA-mediated knock-down. Increased synthesis and ECM deposition of fibronectin was necessary for NME1-induced cell spreading, as knock-down of fibronectin opposed the effects of NME1 on cell morphology. Fibronectin knock-down also reversed the ability of NME1 to promote aggregation when cells were plated on a non-adherent substratum. Similarly, inhibiting activation of the fibronectin receptor integrin 41 with an anti-4 antibody reversed the motility-suppressing effect of NME1. A positive correlation was observed between NME1 and fibronectin mRNA in clinical biopsies of normal skin, benign nevi and primary melanomas, but not in metastatic forms, suggesting the NME1/fibronectin axis represents a barrier to melanoma progression. In summary, these findings indicate fibronectin is an important effector of the motility-suppressing function of NME1 in melanoma cells.
引用
收藏
页码:455 / 461
页数:7
相关论文
共 23 条
  • [1] The metastasis suppressor NME1 inhibits melanoma cell motility via direct transcriptional induction of the integrin beta-3 gene
    Leonard, M. Kathryn
    Novak, Marian
    Snyder, Devin
    Snow, Grace
    Pamidimukkala, Nidhi
    McCorkle, Joseph R.
    Yang, Xiuwei H.
    Kaetzel, David M.
    EXPERIMENTAL CELL RESEARCH, 2019, 374 (01) : 85 - 93
  • [2] The Metastasis Suppressor NME1 Regulates Expression of Genes Linked to Metastasis and Patient Outcome in Melanoma and Breast Carcinoma
    Mccorkle, Joseph R.
    Leonard, Mary K.
    Kraner, Susan D.
    Blalock, Eric M.
    Ma, Deqin
    Zimmer, Stephen G.
    Kaetzel, David M.
    CANCER GENOMICS & PROTEOMICS, 2014, 11 (04) : 175 - 194
  • [3] Dual functions of NME1 in suppression of cell motility and enhancement of genomic stability in melanoma
    Kaetzel, David M.
    Leonard, Mary K.
    Cook, Gemma S.
    Novak, Marian
    Jarrett, Stuart G.
    Yang, Xiuwei
    Belkin, Alexey M.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2015, 388 (02) : 199 - 206
  • [4] A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 is highly metastatic in vivo
    Snyder, Devin
    Wang, Ying
    Kaetzel, David M.
    SCIENTIFIC REPORTS, 2020, 10 (01) : 1971
  • [5] Dual functions of NME1 in suppression of cell motility and enhancement of genomic stability in melanoma
    David M. Kaetzel
    Mary K. Leonard
    Gemma S. Cook
    Marian Novak
    Stuart G. Jarrett
    Xiuwei Yang
    Alexey M. Belkin
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2015, 388 : 199 - 206
  • [6] Metastasis Suppressor NME1 Directly Activates Transcription of the ALDOC Gene in Melanoma Cells
    Pamidimukkala, Nidhi, V
    Leonard, Mary Kathryn
    Snyder, Devin
    Mccorkle, Joseph R.
    Kaetzel, David M.
    ANTICANCER RESEARCH, 2018, 38 (11) : 6059 - 6068
  • [7] Metastasis suppressor NME1 in exosomes or liposomes conveys motility and migration inhibition in breast cancer model systems
    Khan, Imran
    Gril, Brunilde
    Hoshino, Ayuko
    Yang, Howard H.
    Lee, Maxwell P.
    Difilippantonio, Simone
    Lyden, David C.
    Steeg, Patricia S.
    CLINICAL & EXPERIMENTAL METASTASIS, 2022, 39 (05) : 815 - 831
  • [8] Metastasis Suppressor NME1 Modulates Choice of Double-Strand Break Repair Pathways in Melanoma Cells by Enhancing Alternative NHEJ while Inhibiting NHEJ and HR
    Puts, Gemma
    Jarrett, Stuart
    Leonard, Mary
    Matsangos, Nicolette
    Snyder, Devin
    Wang, Ying
    Vincent, Richard
    Portney, Benjamin
    Abbotts, Rachel
    McLaughlin, Lena
    Zalzman, Michal
    Rassool, Feyruz
    Kaetzel, David
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (16) : 1 - 15
  • [9] The prostate metastasis suppressor gene NDRG1 differentially regulates cell motility and invasion
    Sharma, Anup
    Mendonca, Janet
    Ying, James
    Kim, Hea-Soo
    Verdone, James E.
    Zarif, Jelani C.
    Carducci, Michael
    Hammers, Hans
    Pienta, Kenneth J.
    Kachhap, Sushant
    MOLECULAR ONCOLOGY, 2017, 11 (06): : 655 - 669
  • [10] Breast Cancer Metastasis Suppressor 1 Regulates Hepatocellular Carcinoma Cell Apoptosis via Suppressing Osteopontin Expression
    Wu, Yanhua
    Jiang, Wenjun
    Wang, Yingming
    Wu, Jun
    Saiyin, Hexige
    Qiao, Xiaojing
    Mei, Xinyu
    Guo, Bin
    Fang, Xiao
    Zhang, Lu
    Lou, Huiling
    Wu, Chaoqun
    Qiao, Shouyi
    PLOS ONE, 2012, 7 (08):